A Phase 1 Study of NM6603 in Advanced Solid Tumors
Clinical trial NCT06046066 · TERMINATED
Trial details
- NCT number
- NCT06046066
- Sponsor
- NucMito Pharmaceuticals Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2025-04-25
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.